Mountain West AIDS Education and Training Center (MWAETC)

« Return to MWAETC On-Demand Presentations

Cabotegravir plus Rilpivirine (Cabenuva): Extended Release Injectable Suspension

Presentation Date: 2021-02-04

Presentation Length: 17:10

Presenters: David Spach, MD

Presentation Categories: HIV ECHO

Presentation Tags: Anti-Retroviral Therapy (ART), Long- Acting ART/Injectables

Presentation Slides:

Download (741.930 KB)

Presentation Downloads:

Related Documents:

Related Links:

Related Presentations:

Presentation Details:
Dr. David Spach reviews evidence and guidance for long-acting, injectable, cabotegravir-rilpivirine (Cabenuva) as treatment for HIV.

Presentation Transcript:

MOUNTAIN WEST AIDS EDUCATION AND TRAINING CENTER

This website is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $2,982,063 with 0% financed with non-governmental sources. The content in presentations are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government.